340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

HRSA Asks Drugmakers to Verify Their Info in 340B Database

Makes request in connection with new price verification system
 

Print Article

April 28, 2015—The Health Resources and Services Administration has asked drugmakers to verify by May 15 that their information in the 340B program database is complete and up to date. [ms-protect-content id=”2799″]

HRSA made the request in an April 24 “Dear Manufacturer” letter. It explained it was doing so in connection with the congressionally mandated system it is creating “to verify the accuracy of manufacturer-calculated 340B selling prices against HRSA’s calculated 340B ceiling prices.”

“As part of this process and to enhance program integrity, we are requesting that you verify the accuracy and completeness of the information on file for your organization in the 340B program database by May 15, 2015,” the letter states. “Making any necessary corrections today will promote the security and integrity of your sensitive pricing data, as well as facilitate the rollout of the system later this year.” The letter tells manufacturers to “review the database record for each of your labeler codes and submit a manufacturer change request form to 340Bpricing@hrsa.gov if any updates are necessary.”

A few days earlier, HRSA published a Federal Register notice inviting public comment about its plan to collect the following information from drug companies for the 340B price verification system:

  • Average manufacturer price
  • Unit rebate amount
  • Package sizes
  • National drug code
  • Period of sale (year and quarter)
  • Manufacturer-determined 340B ceiling price for each NDC produced by a manufacturer subject to a PPA

Those comments are due on May 21, 2015.

In late 2011, HRSA began requiring health care providers to recertify once a year that they are still eligible for the drug discount program and that all of their information in the 340B database is correct. Congress included this requirement for providers in the Affordable Care Act. There is no comparable statutory or regulatory requirement for drugmakers. [/ms-protect-content]

 

Follow us on X

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
23h

Tennessee’s law protecting #340B pharmacy partnerships stays in effect, per a federal judge in Nashville.
The judge found our amicus brief persuasive and denied @AbbVie’s request to stop the state from enforcing that law.
Alongside our national and regional hospital and…

Reply on Twitter 1942562310955966957 Retweet on Twitter 1942562310955966957 Like on Twitter 1942562310955966957 Twitter 1942562310955966957
340bhealth 340B Health @340bhealth ·
7 Jul

Two judges recently decided drugmakers cannot act unilaterally to upend the decades-old, bipartisan government program known as #340B.
As the legal process continues with appeals, we thank our member hospitals who have helped us defend the health care safety net throughout this…

Reply on Twitter 1942322982820491536 Retweet on Twitter 1942322982820491536 1 Like on Twitter 1942322982820491536 Twitter 1942322982820491536
340bhealth 340B Health @340bhealth ·
7 Jul

Nichole Rochester (@yourgpsdoc) at the upcoming #340BConf will address how to increase humanity in health care. This session, exclusively for 340B Health individual members, will include skill-building and small-group discussions to promote genuine connections that providers can…

Reply on Twitter 1942243710403817888 Retweet on Twitter 1942243710403817888 Like on Twitter 1942243710403817888 Twitter 1942243710403817888
Load More

RSS 340B Informed

  • An In-Depth Look at Total 340B Purchases
  • Ideas for 340B Changes Could Lead to Legislation
  • Help From 340B After a Rare Diagnosis and an Unaffordable Bill

Copyright © 2025 · 340B Health